Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • alex_kur
    Junior Member
    • Sep 2009
    • 8

    Problem in primary analysis

    Hi, I have one problem I can't solve myself.

    I was making run on Solid, and for some reasons solid cluster was rebooted.
    So, instrument was stopped and then resumed. After resuming, imaging and fluidics was OK, but there were no bindFinding and color calling - so now I have only focal maps and images, but don't have any intermediate results such as satay reports and color calling.

    How can I restart primary analisys from raw images? SETS says that primary re-analysis can be made only from color calling, not images.

    So, I think it's the same question as "How is the image processing started directly on SOLiD?"

    I will be very pleased if you help me
    Last edited by alex_kur; 10-28-2010, 11:34 PM.
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    With issues of this sort we contact Applied Biosystems. They can login remotely, if you allow it, and start image analysis for you.

    If this is not possible, I have a way that might work: re-do the focal map. Does not cost much (you can steal the reagent from a WFA kit.) This does not just complete image analysis, it would repeat it from the beginning. We did is once and it took >3 days (~ 1 hour/cycle reprocessed) to completely re-do image analysis! More detail in an earlier thread:



    But getting AB to re-start image analysis for you, would be a much better method with less risk.

    --
    Phillip

    Comment

    • alex_kur
      Junior Member
      • Sep 2009
      • 8

      #3
      Thanks a lot!

      I have written to the AB specialists to solve this problem, but maybe it's too early now in their time zone to answer me.
      Nevertheless, I'm unpleasantly surprised that fact that there no convenient method to restart imaging locally. Maybe it's because of very little probability of this issue...

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Yes, it is rare. Also, because doing image processing is computationally intensive, they may prefer to make it difficult to do -- so it does not happen unintentionally. Or due to a misunderstanding.

        Don't you have tech support you can phone?
        --
        Phillip

        Comment

        • alex_kur
          Junior Member
          • Sep 2009
          • 8

          #5
          Yes, I called them (to our, russian representatives of ABI), but they also don't know how to do it. I think, they are going to contact with their colleagues. So, I hope it's a matter of time...

          Comment

          Latest Articles

          Collapse

          • mylaser
            Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by mylaser
            Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
            If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
            This guide explains everything you need to know about...
            Today, 01:13 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          9 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-07-2026, 11:05 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-02-2026, 11:08 AM
          0 responses
          31 views
          0 reactions
          Last Post SEQadmin2  
          Working...